Log in
Log in
Or log in with
GoogleGoogle
Twitter Twitter
Facebook Facebook
Apple Apple     
Sign up
Or log in with
GoogleGoogle
Twitter Twitter
Facebook Facebook
Apple Apple     
  1. Homepage
  2. Equities
  3. United States
  4. Nasdaq
  5. Ontrak, Inc.
  6. News
  7. Summary
    OTRK   US6833731044

ONTRAK, INC.

(OTRK)
  Report
Delayed Nasdaq  -  04:00:00 2023-02-03 pm EST
1.060 USD   +3.92%
01/19Ontrak Health to Present at the Maxim Group's Healthcare IT Virtual Conference
BU
01/19New data shows significant reduction in depression and anxiety symptoms for ontrak health's innovative wholehealth+ program members
AQ
01/18Ontrak Reports Improvement in Mental Health Data for Wholehealth+ Program; Shares Jump
MT
SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisionsFunds 
SummaryMost relevantAll NewsAnalyst Reco.Other languagesPress ReleasesOfficial PublicationsSector news

Ontrak to Participate at the Lytham Partners Summer 2022 Investor Conference

06/09/2022 | 04:06pm EST

Ontrak, Inc. (NASDAQ: OTRK) (“Ontrak” or the “Company”), a leading AI-powered and telehealth-enabled healthcare company, today announced the company will be participating in the upcoming Lytham Partners Summer 2022 Investor Conference.

Dates: Tuesday, June 21, 2022 to Wednesday, June 22, 2022
Format: Presentation available beginning on June 21, 2022, at 9:00 a.m. Eastern Time

Interested parties may access the presentation on the “Investors” section of the company’s website at: https://ontrakhealth.com/investors/presentations-events.

About Ontrak, Inc.

Ontrak, Inc. is a leading AI and telehealth-enabled healthcare company, whose mission is to help improve the health and save the lives of as many people as possible. Ontrak identifies, engages, activates and provides care pathways to treatment for the most vulnerable members of the behavioral health population who would otherwise fall through the cracks of the healthcare system. We engage individuals with anxiety, depression, substance use disorder and chronic disease through personalized care coaching and customized care pathways that help them receive the treatment and advocacy they need, despite the socio-economic, medical and health system barriers that exacerbate the severity of their comorbid illnesses. The company’s integrated intervention platform uses AI, predictive analytics and digital interfaces combined with dozens of care coach engagements to deliver improved member health, better healthcare system utilization, and durable outcomes and savings to healthcare payors.

Learn more at www.ontrakhealth.com


ę Business Wire 2022
All news about ONTRAK, INC.
01/19Ontrak Health to Present at the Maxim Group's Healthcare IT Virtual Conference
BU
01/19New data shows significant reduction in depression and anxiety symptoms for ontrak heal..
AQ
01/18Ontrak Reports Improvement in Mental Health Data for Wholehealth+ Program; Shares Jump
MT
01/18Top Midday Gainers
MT
01/18New Data Shows Significant Reduction in Depression and Anxiety Symptoms For Ontrak Heal..
BU
01/09Ontrak Health and Optima Health Sign New Amendment to Impact Highest Acuity Members
BU
01/09Ontrak, Inc. and Optima Health Signs New Amendment to Impact Highest Acuity Members
CI
01/04Ontrak, Inc. : Entry into a Material Definitive Agreement, Financial Statements and Exhibi..
AQ
2022Prestigious American Journal of Managed Care Publishes Landmark Ontrak Treatment Effect..
BU
2022Ontrak Announces Receipt of Notice from Nasdaq Regarding Non-Compliance of its 9.50% Se..
AQ
More news
Analyst Recommendations on ONTRAK, INC.
More recommendations
Financials (USD)
Sales 2021 84,1 M - -
Net income 2021 -37,1 M - -
Net cash 2021 18,8 M - -
P/E ratio 2021 -2,55x
Yield 2021 -
Capitalization 28,9 M 28,9 M -
EV / Sales 2020 12,6x
EV / Sales 2021 1,21x
Nbr of Employees 241
Free-Float 62,7%
Chart ONTRAK, INC.
Duration : Period :
Ontrak, Inc. Technical Analysis Chart | MarketScreener
Full-screen chart
Technical analysis trends ONTRAK, INC.
Short TermMid-TermLong Term
TrendsBullishBullishNeutral
Income Statement Evolution
Consensus
Mean consensus -
Number of Analysts 0
Last Close Price 1,06
Average target price
Spread / Average Target -
EPS Revisions
Managers and Directors
Terren S. Peizer Executive Chairman & Chief Executive Officer
Brandon H. LaVerne Co-President & Chief Operating Officer
Mary Louise Osborne Co-President & Chief Commercial Officer
James J. Park Chief Financial & Accounting Officer
Arik Hill Chief Information Officer